High human immunodeficiency virus type 1 RNA load in the cerebrospinal fluid from patients with lymphocytic meningitis

Journal of Infectious Diseases

Volumn 177, Issue 2, 1998, Pages 473-476

  Morris, Lynn ^a   Silber, Eli ^b   Sonnenberg, Pamela ^c   Eintracht, Shaun ^c   Nyoka, Stephina ^c   Lyons, Susan F ^c   Saffer, David ^c   Koornhof, Hendrik ^c   Martin, Desmond J ^c  

^a AARON DIAMOND AIDS RESEARCH CENTER   (United States)

^b CHARING CROSS HOSPITAL   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; ASEPTIC MENINGITIS; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; DEMENTIA; EPIDEMIC MENINGITIS; FUNGAL MENINGITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTIC INFILTRATION; MENINGITIS; PRIORITY JOURNAL; TUBERCULOMA; TUBERCULOUS MENINGITIS; VIRUS TITRATION;

EID: 0031908242     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/517379     Document Type: Article

References (15)

1. Price RW. Neurological complications of HIV infection. Lancet 1996;348:445-52.
2. McArthur JC. Neurologic diseases associated with HIV-1 infection. Curr Opin Infect Dis 1995;8:74-84.
3. Chiodi F, Keys B, Albert J, et al. Human immunodeficiency virus type 1 is present in the cerebrospinal fluid of a majority of infected individuals. J Clin Microbiol 1992;30:1768-71.
4. Spector SA, Hsia K, Pratt D, et al. Virologie markers of human immunodeficiency virus type 1 in cerebrospinal fluid. J Infect Dis 1993;168:68-74.
5. Mellors JW, Rinaldo CR, Gupta P, White RM, Todd JA, Kingsley LA. Progress in HIV infection predicted by the quantity of virus in plasma. Science 1996;272:1167-70.
6. Pratt RD, Nichols S, McKinney N, Kwok S, Dankner WM, Spector SA. Virologie markers of human immunodeficiency virus type 1 in cerebrospinal fluid of infected children. J Infect Dis 1996;174:288-93.
7. Conrad AJ, Schmid P, Syndulko K, et al. Quantifying HIV-1 RNA using the polymerase chain reaction on cerebrospinal fluid and serum of seropositive individuals with and without neurologic abnormalities. J Acquir Immune Defic Syndr 1995;10:425-35.
8. Goswami KK, Miller RF, Harrison MJ, Hamel DJ, Daniels RS, Tedder RS. Expression of HIV-1 in the cerebrospinal fluid detected by the polymerase chain reaction and its correlation with central nervous system disease. AIDS 1991;5:797-803.
9. Weiser B, Peress N, La Neve D, Eilbott DJ, Seidman R, Burger H. Human immunodeficiency virus type 1 expression in the central nervous system correlates directly with extent of disease. Proc Natl Acad Sci USA 1990;87:3997-4001.
10. Shaunak S, Albright RE, Klotman ME, Henry SC, Bartlett JA, Hamilton JD. Amplification of HIV-1 provirus from cerebrospinal fluid and its correlation with neurologic disease. J Infect Dis 1990;161:1068-72.
11. Brew BJ, Pemberton L, Cunningham P, Law MG. Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. J Infect Dis 1997;175:963-6.
12. Quagliarello V, Scheid WM. Bacterial meningitis: pathogenesis, pathophysiology, and progress. N Engl J Med 1992;327:864-72.
13. De Cock KM, Soro B, Coulibaly IM, Lucas SB. Tuberculosis and HIV infection in sub-Saharan Africa. JAMA 1992;268:1581-7.
14. Pettoello-Mantovani M, Casadevall A, Kollmann TR, Rubinstein A, Goldstein H. Enhancement of HIV-1 infection by the capsular polysaccharide of Cryptococcus neoformans. Lancet 1992;339:21-3.
15. Lederman MM, Georges DL, Kusner DJ, Mudido P, Giam CZ, Toossi Z. Mycobacterium tuberculosis and its purified protein derivative activate expression of the human immunodeficiency virus. J Acquir Immune Defic Syndr 1994;7:727-33.